She just made a great decision about her financial future in less than 15 minutes.

See How!
 
Invest like a Pro Contest

Test your investing skills risk free and win real cash prizes

AlphaStreet is a complete social ecosystem that significantly reduces the complexity and friction in making investment decisions.

Alpha Street Feed

Access many great features on the go

Now available on iPhone

Alpha Street Feed

AlphaBites

Financial news distilled down to the essentials.

Our team keeps a pulse on important financial news & data; distilling it down to easily digestible and actionable bite-sized snippets. No longer do you need to sift through news and research full of unintelligible language and numbers that make your head spin. We filter the good stuff so you don't have to waste time.

One of my new favorite follows: @AlphaStreet. Incredible live updates, charts, and earnings news coming from them. Visuals are great.

Stefan Cheplick, StockTwits
$PFE {{ '2017-03-23T22:57:39+0000' | timeago}} • Announcement

$PFE announced that the US Food and Drug Administration (FDA) has approved BAVENCIO (avelumab) Injection 20 mg/mL, for intravenous use.

$LW {{ '2017-03-23T22:53:10+0000' | timeago}} • Announcement

$LW's BoD declared a quarterly dividend of $0.1875 per share of common stock. The dividend is payable on June 2, 2017, to stockholders of record on April 30, 2017.

$M {{ '2017-03-23T22:47:58+0000' | timeago}} • Announcement

$M said its board of directors elected Jeff Gennette as CEO, effective March 23, 2017. Mr. Gennette succeeds Terry J. Lundgren, who will continue as Executive Chairman.

$UDR {{ '2017-03-23T22:43:38+0000' | timeago}} • Announcement

$UDR announced that its Board of Directors declared a regular quarterly dividend on its Series E preferred stock for 1Q17 of $0.3322 per share. The preferred dividend is payable on May 1, 2017 to Series E preferred stock shareholders of record as of April 10, 2017.

$UDR {{ '2017-03-23T22:43:18+0000' | timeago}} • Announcement

$UDR's BoD declared a quarterly dividend of $0.31 per common share for 1Q17 payable on May 1, 2017 to shareholders of record as of April 10, 2017. The company’s annualized and declared common dividend of $1.24 per share for 2017 represents a 5% increase over the annualized and declared common dividend of $1.18 per share in 2016.

Investing has never been this

EMPOWERING

AlphaTalk

Engage with your peers and experts

Participate in conversation with your peers and experts in the field. Post your opinions and get valuable feedback on the topics you're interested in and validate your investment theories. Gain a reputation and following, easily share to popular social media sites.

User Ashton Alloway {{ '2017-03-23T23:39:05+0000' | timeago}}

Stocks sink after vote on health bill is delayed!! Market ended up mostly lower after having a promising start.

User Frankie Joe {{ '2017-03-23T22:22:50+0000' | timeago}}

$DAL has good news for New York - Rio de Janiero fliers. Delta plans to start new daily non-stop service between JFK and GIG in Dec. 2017.

User Mark Collas {{ '2017-03-23T22:12:30+0000' | timeago}}

Wow!! $MU’s shares rising rapidly. I guess that’s because they beat their second quarter earnings estimates.

User Robin Edwards {{ '2017-03-23T20:53:39+0000' | timeago}}

Great again!! Job market looks healthy now. Unemployment benefit applications are still at a low level.

User Melwyn Jones {{ '2017-03-23T19:37:36+0000' | timeago}}

It’s not much surprising $FTR shares hit an all-time low as the decline was consistent since the beginning of the year.

Investing has never been this SOCIAL

Social Sentiment

Social Sentiment

Know what your peers and pros think

Investing is complicated and noisy. Your friends, colleagues and many professionals share their opinions and you get to see their consensus of the stocks you're interested in. Presented with concise language and visuals, you can make your decision with ease... are you going to follow or buck the trend?

Investing has never been this

SIMPLE

 

Smart Portfolio

Easily discover and see how you are faring

Take the pain out of discovering new stocks and get an intelligent birds-eye view of the stock you're interested in or invested in. A single intuitive interface gives you the perspective to make important decisions and balance your portfolio like a professional. Seamlessly integrate your brokerage accounts trade and track your investments.

 

AlphaStreet will enable you to make informed decisions
in under 15 minutes.